Umeclidinium
Back to searchMolecule Structure
Scientific Name
Umeclidinium
Description of the Drug
Umeclidinium is a long-acting muscarinic antagonist used as a long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09076
http://www.drugbank.ca/drugs/DB09076
Brand Name(s)
Not Available
Company Owner(s)
Glaxo Group Ltd England Dba Glaxosmithkline, Glaxosmithkline Intellectual Property Development Ltd England
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2033192 | |
| DrugBank | DB09076 | |
| PubChem | 11519070 | |
| LINCS | LSM-45495 | |
| Nikkaji | J3.280.819K | |
| BindingDB | 50267614 | |
| EPA CompTox Dashboard | DTXSID00235971 | |
| DrugCentral | 4816 | |
| Guide to Pharmacology | 7354 | |
| rxnorm | UMECLIDINIUM | UMECLIDINIUM BROMIDE |
| ZINC | ZINC000034608502 |
